Search results
This Pharma Stock Is Poised to Keep Outperforming the S&P 500 | The Motley Fool
The Motley Fool· 6 days agoAstraZeneca (AZN 1.24%), recognized as the world's sixth-largest pharmaceutical entity by market...
AstraZeneca (NASDAQ:AZN) Now Covered by Analysts at The Goldman Sachs Group
ETF DAILY NEWS· 5 days agoThe Goldman Sachs Group assumed coverage on shares of AstraZeneca (NASDAQ:AZN – Free Report) in a research report report published on Thursday morning, Marketbeat Ratings ...
Earnings call: Cellectis reports an additional investment of $140 million from AstraZeneca By...
Investing.com· 6 days agoIn their first quarter 2024 earnings call, Cellectis, a biopharmaceutical company, presented a...
AstraZeneca shares target raised by Argus on new drug approvals By Investing.com
Investing.com· 6 days agoOn Thursday, AstraZeneca PLC (NASDAQ:LON:AZN) shares received an updated price target from a market...
Parallel Advisors LLC Sells 169 Shares of AstraZeneca PLC (NASDAQ:AZN)
ETF DAILY NEWS· 6 days agoParallel Advisors LLC reduced its stake in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 1.2% during the fourth quarter, according to the company in its most recent 13F filing ...
AstraZeneca CEO Has No Plans to Retire as He Seeks to Nearly Double Sales by 2030
The Wall Street Journal· 5 days agolongest-serving chief executive, Pascal Soriot, has no plans to step down for now as the company...
3 No-Brainer Stocks to Buy in June
Motley Fool via Yahoo Finance· 3 days agoBut what does June bring? Three Motley Fool contributors think the new month should usher in great investing opportunities. Here's why they picked AbbVie...
Amgen Secures FDA Nod For Rare-Disease Treatment Biosimilar Based On AstraZeneca's Drug
Benzinga via Yahoo Finance· 7 days agoTuesday, the FDA approved Amgen Inc (NASDAQ:AMGN) Bkemv (eculizumab-aeeb) as the first...
Chasing Merck, AstraZeneca's PCSK9 inhibitor lowers cholesterol in phase 1 test
FierceBiotech· 7 days agoAstraZeneca’s small molecule lowered levels of “bad” cholesterol by more than half in patients who...
Compugen hits milestone with AstraZeneca cancer trial By Investing.com
Investing.com· 6 days agoThe trial is a crucial step in evaluating the drug as a first-line treatment for a specific type of...